Wockhardt share news, announcements and annual reports
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Wockhardt Limited · Face value ₹5 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000
Last close ₹1,896.50down ₹4.60 (0.24%)BSE ₹1,892.15
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,901.10.
2 Nov: open ₹1,903.10, high ₹1,915.00, low ₹1,864.10
52-week range of traded prices to 2 Nov 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹30,817 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 75.16
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.97
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.39
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 6,06,59351.5% delivered
Wockhardt share news and announcements
1,014 announcements, routine notices left out, newest first. Page 20 of 21.
Apr 2008
28 Apr · Results
Consolidated Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 78570 lacs for quarter ending on 31-MAR-2008 against Rs. 52280 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 5090 lacs for the quarter ending on 31-MAR-2008 against Rs. 6630 lacs for the quarter ending on 31-MAR-2007.16 Apr · Meeting
Notice of the Annual General Meeting of the members of the Company to be held on April 28, 2008. Further the company has submitted to the Exchange a copy of Addendum to notice of Annual General Meeting. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Apr · Board meeting
To consider and approve the unaudited financial results of the Company for the quarter ended March 31, 2008.
Mar 2008
24 Mar · Business
Press release dated March 20, 2008, titled "No impact of derivatives on Wockhardt". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
20 Feb · Updates
Statement of Appropriation for the financial year 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Feb · Results
Standalone Results for the year ended on 31-DEC-2007 as follows: Net Sales of Rs. 123680 lacs for year ending on 31-DEC-2007 against Rs. 113450 lacs for the year ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 21390 lacs for the year ending on 31-DEC-2007 against Rs. 21350 lacs for the year ending on 31-DEC-2006.20 Feb · Results
Standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 29540 lacs for quarter ending on 31-DEC-2007 against Rs. 25000 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 3390 lacs for the quarter ending on 31-DEC-2007 against Rs. 4850 lacs for the quarter ending on 31-DEC-2006.20 Feb · Dividend
At the meeting of Board of Directors of the Company held on February 20, 2008, the following business were transacted amongst others: 1) The Board has recommended a final dividend of Rs. 2.50 per equity share i.e. 50% for the year 2007. An interim dividend of Rs. 8.75 per equity share i.e. 175% was paid in November 2007. Accordingly, the total dividend for the financial year ended December 31, 2007 is Rs. 11.25 per equity share i.e. 225%. 2) The Register of Members and Share Transfer Books will remain closed from April 22, 2008 to April 28, 2008 (both days inclusive) for the purpose of payment of dividend and Annual General Meeting.20 Feb · Results
Consolidated Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 76200 lacs for quarter ending on 31-DEC-2007 against Rs. 52640 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 10690 lacs for the quarter ending on 31-DEC-2007 against Rs. 8710 lacs for the quarter ending on 31-DEC-2006.20 Feb · Results
Consolidated Results for the year ended on 31-DEC-2007 as follows: Net Sales of Rs. 265320 lacs for year ending on 31-DEC-2007 against Rs. 172900 lacs for the year ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 38580 lacs for the year ending on 31-DEC-2007 against Rs. 24130 lacs for the year ending on 31-DEC-2006.13 Feb · Business
Press release dated February 12, 2008, titled "Wockhardt enters the US market with Zithromax". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.5 Feb · Board meeting
For transacting the following business amongst others: (1) Approval of the audited accounts of the Company for the year ended December 31, 2007. (2) Publishing of the audited results for the quarter and year ended December 31, 2007. (3) Recommendation of final dividend.
Jan 2008
28 Jan · Disclosure
Annual declaration received by the Company from its Directors /Officers for the year ended December 31, 2007 as per letter dated January 28, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Jan · Disclosure
Annual declaration received by the Company from its Directors /Officers for the year ended December 31, 2007 as per letter dated January 21, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Jan · Board meeting
Vide its letter dated January 18, 2008, that: "A meeting of Board of Directors of the Company held today the following business was transacted amongst others:1) Subject to the approval of shareholders, creditors and regulatory bodies the Board provided its in-principle approval to demerge the new drug discovery programme and the innovative new technologies R&D. 2) Subject to the approval of the shareholders and regulatory bodies the board approved raising of funds upto US$ 200 million through issuance of equity / equity linked securities to expand its domestic and international business. 3) Convene an extra-ordinary general meeting of the members of the Company on February 20, 2008 for obtaining the approval of shareholders to raise funds upto US$ 200 million". Further, the Company has submitted to the Exchange a copy of the press release dated January 18, 2008, titled "Wockhardt to restructure its R&D business". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.10 Jan · Board meeting
To consider the following: (1) In Principle approval of the board to demerge New Chemical Entities (NCE) R&D and certain high value products R&D carried out by the Company, subject to the approval of shareholders and other regulatory authorities. (2) Raising of funds through further issue of equity/ equity linked securities, subject to the approval of shareholders.9 Jan · Business
Press release dated January 09, 2008, titled "Wockhardt to launch generic version of anti-depressant Zoloft in the US market". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Jan · Results
The Company will be publishing audited results for the year ended December 31, 2007 and for the quarter ended on that date and in view of this the unaudited results will not be published1 Jan · Business
Press release dated January 01, 2008, titled "Wockhardt enters billion-dollar anti-allergic Zyrtec market in the US". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2007
24 Oct · Business
Press release dated October 24, 2007, titled "Wockhardt acquires Morton Grove in the US". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Oct · Dividend
Board, at its meeting held on October 23, 2007 has declared a Interim Dividend of 175% i.e. Rs.8.75 per equity share, for the year ending December 31, 2007.23 Oct · Results
Consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 73810 lacs for quarter ending on 30-SEP-2007 against Rs. 43770 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 10830 lacs for the quarter ending on 30-SEP-2007 against Rs. 7400 lacs for the quarter ending on 30-SEP-2006.17 Oct · Business
Press release dated October 17, 2007, titled "Wockhardt to market SAMMY-a patented process tablet for Osteoarthritis". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Oct · Business
Press release dated October 15, 2007, titled "Wockhardt to market patented Zindaclin cream; The market for Acne cure in India is worth Rs 1680 million". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.11 Oct · Corporate action
The Company has fixed Monday, October 29, 2007 as the Record date for the purpose of payment of interim dividend on Equity shares for the financial year 2007, if approved by the Board at its meeting to be held on October 23, 200710 Oct · Board meeting
For: 1) Approving the unaudited results of the Company for the quarter and nine months ended September 30, 2007; and 2) For considering the Interim Dividend for the year 2007.
Sep 2007
17 Sep · Business
Press release dated September 17, 2007, titled "Wockhardt gets US FDA nod to enter the US$ 2.6 billion Norvasc market". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2007
28 Aug · Limited Review Report
Auditor's have conducted the limited review of the un-audited financial results for the quarter ended June 30, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2007
25 Jul · Results
Consolidated Results for the half year ended on 30-JUN-2007 as follows: Net Sales of Rs. 115310 lacs for half year ending on 30-JUN-2007 against Rs. 76370 lacs for the half year ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 16870 lacs for the half year ending on 30-JUN-2007 against Rs. 5980 lacs for the half year ending on 30-JUN-2006.25 Jul · Results
Standalone Results for the half year ended on 30-JUN-2007 as follows: Net Sales of Rs. 59650 lacs for half year ending on 30-JUN-2007 against Rs. 54830 lacs for the half year ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 12110 lacs for the half year ending on 30-JUN-2007 against Rs. 5440 lacs for the half year ending on 30-JUN-2006.25 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 63030 lacs for quarter ending on 30-JUN-2007 against Rs. 41270 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 10240 lacs for the quarter ending on 30-JUN-2007 against Rs. 6340 lacs for the quarter ending on 30-JUN-2006.25 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 30380 lacs for quarter ending on 30-JUN-2007 against Rs. 28650 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 6910 lacs for the quarter ending on 30-JUN-2007 against Rs. 4950 lacs for the quarter ending on 30-JUN-2006.13 Jul · Board meeting
For approving the unaudited results of the Company for the quarter and half year ended June 30, 2007.9 Jul · Business
Press release dated July 09, 2007, titled "Wockhardt to launch anti-epileptic injection, Fosphenytoin, in the US". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jun 2007
20 Jun · Business
Press release dated June 20, 2007, titled "Wockhardt to launch Cefprozil, in the US". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Jun · News Verification
News Verification : The media had reports that Wockhardt Limited may buy US based generic drug maker Morton Grove Pharma. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Wockhardt Limited has vide its letter inter-alia stated,"The Company is strategically open to acquisition opportunities both in India and abroad and in case anything materializes the Company will disclose the same at the appropriate time."
May 2007
31 May · Business
Press release dated May 31, 2007, titled "Wockhardt gets US FDA nod to enter the $680 million Lamisil market; Seventh ANDA approval in 3 months". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 May · Business
Press release dated May 21, 2007, titled "Wockhardt launches insomnia drug Zolpidem in the US; Six US FDA approvals in two months". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 May · Limited Review Report
Auditors have conducted the limited review of the un-audited financial results for the quarter ended March 31, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 May · Business
Press release dated May 16, 2007, titled "Wockhardt completes the acquisition of Negma Laboratories in France". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 May · Business
Press release, dated May 3, 2007, titled "Wockhardt acquires Negma Laboratories in France." A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.3 May · Business
May 03, 2007 that " the Company has entered into an agreement with Ifrah Finance S.A. of France to acquire Negma Lerads S.A.S, a French Pharmaceutical Group having a sales turnover of US$ 150 million during the last financial year".
Apr 2007
24 Apr · Meeting
Notice of the Annual General Meeting to be held on May 18, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Apr · Business
Press release dated April 24, 2007, titled "Wockhardt receives US FDA approval for anti-hypertensive drug". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.23 Apr · Business
Press release dated April 23, 2007, titled "Wockhardt to launch Italy's B-Lift range of dermatology products in India". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.17 Apr · Business
Press release dated April 17, 2007, titled "Wockhardt to soon introduce Kelocote to treat scars". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Apr · Business
Press release dated April 16, 2007, titled "Wockhardt gets US FDA nod to market full range of Ceftriaxone antibiotic injection in US". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Apr · Board meeting
For approving the unaudited results of the Company for the quarter ended March 31, 2007.10 Apr · Meeting
Pursuant to section 154 of the Companies Act, 1956 Register of Members and share Transfer Books of the Company will remain closed from May 14, 2007 to May 18, 2007 (both days inclusive) for the purpose of the Annual General Meeting to be held on May 18, 2007.
Mar 2007
28 Mar · Business
Press release dated March 28, 2007, titled "Wockhardt receives US FDA approval for anti-inflammatory injection". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.